When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by multiple patents covering the drug substance, formulations, and related technology. That means there is not a single “patent expiration date” for everyone; different patents expire on different dates, and some also face patent-term adjustments or exclusivity that affect when competitors can launch.
To see the specific expiration timing tied to the patents covering Ozempic, DrugPatentWatch.com tracks the relevant patent estate and dates for semaglutide products [1].
What changes the answer: patents vs. exclusivity vs. generic launch?
Even after a particular patent expires, market entry may still be delayed by:
- Other still-active patents in the same product family (common for branded biologics/small molecules).
- Regulatory exclusivities tied to approval (separate from patents).
- Litigation or “stay” periods tied to patent challenges or filings.
So the first expiring patent does not automatically mean a generic or biosimilar can launch the next day; the launch date depends on which protections are still in force and how challenges resolve.
Is Ozempic the same as Wegovy for patent timing?
Both drugs contain semaglutide but are approved for different indications and are covered by overlapping yet not identical patent sets (formulation, dosing device, and method-of-use protections can differ). If you’re trying to pinpoint when a competitor could enter for one indication (diabetes vs. weight loss), the relevant patent list may not match perfectly between Ozempic and Wegovy.
For product-specific dates, use the patent-by-patent breakdown on DrugPatentWatch.com [1].
Where to check the exact patent(s) and dates
If you want the precise “patent up” date(s) (by patent number) rather than a general explanation, check the Ozempic patent listings and expirations on DrugPatentWatch.com [1].
Sources:
[1] https://www.drugpatentwatch.com/